Transplantable human non-Hodgkin lymphoma line in artificially immunesuppressed mice.
Diffuse non-Hodgkin lymphoma of B-cell origin has been established as a serially transplantable xenograft line in artificially immunesuppressed mice. The take rate and growth rate increased with repeated passages compared to the first transplant generation. However the xenografted tumor preserved many of its characteristics, including morphology, cell surface markers and DNA index. Chromosome analysis proved the human origin of tumors grown in mice and revealed translocation 8,14. Cyclophosphamide, Methotrexate and Vincristine produced substantial inhibition of tumor growth, while Dianhydrogalactitol and Adriamycin were less effective. Human alpha interferon also produced a delay in tumor growth.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002455:Cell Division; D002460:Cell Line; D006801:Humans; D007165:Immunosuppression Therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology*; D051379:Mice; D008854:Microscopy, Electron; D009368:Neoplasm Transplantation